Drugs / 68Ga-NOTA Evans Blue
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05140083 | Apr 2021 → Dec 2024 | — | First Affiliated Hospital of Fujian Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-NOTA Evans Blue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05140083 ↗ |
| Modality | Diagnostic / imaging agent | “68Ga-NEB positron emission tomography/computed tomography (PET/CT)” NCT05140083 ↗ |
| Route | Subcutaneous | “will be injected subcutaneously” NCT05140083 ↗ |